Drug and medical device companies are continuously facing the threat of litigation, mass tort proceedings, and a negative public image. To address these and other issues, IQPC hosted a conference in New York City on 27-28 March 2007. NERA Senior Vice President Dr. Faten Sabry participated on a panel entitled "Structuring and Administering Mass Torts Settlements." Her presentation included analysis of forecasting future claims for established defendants and for defendants with little or no litigation history. She also discussed the impact of causation and publicity on increasing claim flows.